This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
HSP90 Heat-Shock Proteins; Melanoma; Skin Neoplasms; Triazoles; Uveal Neoplasms
|
|
information resource reference
|
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma. Melanoma Res. 2018 12; 28(6):605-610.
|
|
label
|
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma.
|